These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31020782)

  • 1. Stabilizing p-Dithiobenzyl Urethane Linkers without Rate-Limiting Self-Immolation for Traceless Drug Release.
    Zheng Y; Shen Y; Meng X; Wu Y; Zhao Y; Wu C
    ChemMedChem; 2019 Jun; 14(12):1196-1203. PubMed ID: 31020782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a Thiol-Responsive, Traceless Prodrug with Rapid Self-Immolation for Cancer Chemotherapy.
    Liu G; Jiang Z; Lovell JF; Zhang L; Zhang Y
    ACS Appl Bio Mater; 2021 Jun; 4(6):4982-4989. PubMed ID: 35007046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles.
    Wang Y; Wang X; Deng F; Zheng N; Liang Y; Zhang H; He B; Dai W; Wang X; Zhang Q
    J Control Release; 2018 Jun; 279():136-146. PubMed ID: 29655991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual prodrugs containing bio-cleavable and drug releasable disulfide linkers.
    Jain AK; Gund MG; Desai DC; Borhade N; Senthilkumar SP; Dhiman M; Mangu NK; Mali SV; Dubash NP; Halder S; Satyam A
    Bioorg Chem; 2013 Aug; 49():40-8. PubMed ID: 23886697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
    Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR-targeted prodrug activation using bioorthogonal alkene-azide click-and-release chemistry.
    Fairhall JM; Camilli JC; Gibson BH; Hook S; Gamble AB
    Bioorg Med Chem; 2021 Sep; 46():116361. PubMed ID: 34411983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversing the undesirable pH-profile of doxorubicin via activation of a di-substituted maleamic acid prodrug at tumor acidity.
    Zhang A; Yao L; An M
    Chem Commun (Camb); 2017 Nov; 53(95):12826-12829. PubMed ID: 29143021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-Responsive Prodrug with Aggregation-Induced Emission Probe for Controlled Drug Delivery and Drug Release Tracking in Living Cells.
    Cheng Y; Huang F; Min X; Gao P; Zhang T; Li X; Liu B; Hong Y; Lou X; Xia F
    Anal Chem; 2016 Sep; 88(17):8913-9. PubMed ID: 27503607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol-Free Drugs.
    Riber CF; Smith AA; Zelikin AN
    Adv Healthc Mater; 2015 Aug; 4(12):1887-90. PubMed ID: 26109168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation.
    Miller MA; Mikula H; Luthria G; Li R; Kronister S; Prytyskach M; Kohler RH; Mitchison T; Weissleder R
    ACS Nano; 2018 Dec; 12(12):12814-12826. PubMed ID: 30550257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulated Fragmentation of Proapoptotic Peptide Nanoparticles Regulates Cytotoxicity.
    Suma T; Cui J; Müllner M; Fu S; Tran J; Noi KF; Ju Y; Caruso F
    J Am Chem Soc; 2017 Mar; 139(11):4009-4018. PubMed ID: 28286953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-responsive drug release and fluorescence imaging based on disulfide-pillar[4]arene aggregate in cancer cells.
    Tang M; Liu YH; Xu XM; Zhang YM; Liu Y
    Bioorg Med Chem; 2022 Mar; 57():116649. PubMed ID: 35131545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric prodrug microspheres with tumor intracellular microenvironment bioreducible degradation, pH-triggered "off-on" fluorescence and drug release for precise imaging-guided diagnosis and chemotherapy.
    Pei M; Li G; Ma K; Li J; Wang Y; Liu P
    Colloids Surf B Biointerfaces; 2019 May; 177():313-320. PubMed ID: 30771583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugation of Doxorubicin to siRNA Through Disulfide-based Self-immolative Linkers.
    Gauthier F; Bertrand JR; Vasseur JJ; Dupouy C; Debart F
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32545345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity.
    Yang Y; Sun B; Zuo S; Li X; Zhou S; Li L; Luo C; Liu H; Cheng M; Wang Y; Wang S; He Z; Sun J
    Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33148644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic study of the covalent loading of paclitaxel via disulfide linkers for controlled drug release.
    Yuan L; Chen W; Hu J; Zhang JZ; Yang D
    Langmuir; 2013 Jan; 29(2):734-43. PubMed ID: 23252889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma-targeted delivery system (part 1): design, synthesis and evaluation of releasable disulfide drug by glutathione.
    El Aissi R; Chezal JM; Tarrit S; Chavignon O; Moreau E
    Eur J Med Chem; 2015 Aug; 101():668-80. PubMed ID: 26210505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of a photoresponsive doxorubicin/combretastatin A4 hybrid prodrug.
    Liu W; Liang L; Zhao L; Tan H; Wu J; Qin Q; Gou X; Sun X
    Bioorg Med Chem Lett; 2019 Feb; 29(3):487-490. PubMed ID: 30553736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of paclitaxel and doxorubicin using mixed micelles based on the redox sensitive prodrugs.
    Yang M; Ding H; Zhu Y; Ge Y; Li L
    Colloids Surf B Biointerfaces; 2019 Mar; 175():126-135. PubMed ID: 30529818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.